文献速递乳房整形与再造创面修复

腹壁自体乳房再造后切口疝:1600例连续患者的发生率、修补技术与结局

Incisional Hernia Incidence, Repair Techniques, and Outcomes Based on 1600 Consecutive Patients Receiving Abdominally Based Autologous Breast Reconstruction.
PubMed 文献 · Ann Plast Surg · 2021-01-01

修补时79%使用补片,合成补片较生物补片显著降低复发疝发生率(10.6% vs 38.5%,P=0.017)。结论为尽可能使用补片修补。

要点

  • 腹壁自体乳房再造后供区切口疝发生率为3.6%。
  • 疝修补时合成补片复发率显著低于生物补片(10.6% vs 38.5%,P=0.017)。
  • 补片位置对结局无显著影响,但sublay位置零不良结局。

核心结论

  • 腹壁自体乳房再造后切口疝应尽可能使用补片修补。
  • 合成补片较生物补片显著降低复发疝发生率。
  • 首选retrorectus(腹膜后)补片修补,但该平面常不存在或瘢痕化。

研究设计与样本

  • 回顾性识别2009年1月1日至2016年8月31日期间在宾夕法尼亚大学接受腹壁自体乳房再造的1600例连续患者。
  • 收集术前和手术信息,按皮瓣类型和供区闭合技术确定切口疝发生率。
  • 确定所有接受切口疝修补患者的修补技术和术后结局,并进行单因素和多因素分析。

主要发现

  • 该卫生系统内腹壁自体乳房再造后切口疝发生率为3.6%(n=61)。
  • 疝修补时79%(n=60)使用补片,其中生物补片13例、合成补片47例。
  • 合成补片较生物补片复发疝发生率显著更低(10.6% vs 38.5%,P=0.017)。
  • 补片位置对结局无统计学显著影响,但sublay位置补片零不良结局。

关键数值与推荐

  • 腹壁自体乳房再造后切口疝发生率为3.6%(n=61/1600)。
  • 疝修补补片使用率为79%(n=60/76),其中合成补片47例、生物补片13例。
  • 合成补片复发疝发生率10.6%,生物补片38.5%(P=0.017)。
  • sublay补片位置不良结局为零。

临床怎么用

  • 腹壁自体乳房再造后切口疝修补应尽可能使用补片。
  • 优先考虑retrorectus补片修补;若该平面不存在或瘢痕化,可考虑腹膜内underlay补片联合筋膜原发闭合,或原发闭合联合onlay补片。
  • 合成补片在降低复发疝方面优于生物补片。

局限性

  • 回顾性研究设计。
  • 单中心数据,部分患者来自外院转诊。
  • 补片位置对结局无显著影响,但sublay零不良结局可能受样本量限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As the number of postmastectomy patients who receive abdominally based autologous breast reconstruction (ABABR) increases, the frequency of unique paramedian incisional hernias (IHs) at the donor site is increasing as well. We assessed incidence, repair techniques, and outcomes to determine the optimal treatment for this morbid condition. METHODS: A total of 1600 consecutive patients who underwent ABABR at the University of Pennsylvania between January 1, 2009, and August 31, 2016, were retrospectively identified. Preoperative and operative information was collected for these patients. Incisional hernia incidence was determined by flap type and donor site closure technique. Repair techniques and postoperative outcomes for all patients receiving IH repair (IHR) after ABABR at our institution were also determined. Univariate and multivariate analyses were conducted. RESULTS: The incidence of IH after ABABR in our health system was 3.6% (n = 61). Fifteen additional patients were referred from outside hospitals for a total of 76 patients who received IHR. At the time of IHR, mesh was used in 79% (n = 60) of cases (13 biologic and 47 synthetic), with synthetics having significantly lower recurrent IH incidence (10.6% vs 38.5%, P = 0.017) when compared with biologics. Mesh position did not have any statistically significant effect on outcomes; however, sublay mesh position had zero adverse outcomes. CONCLUSIONS: Mesh should be used in all cases when possible. Although retrorectus repair with mesh is optimal, this plane is often nonexistent or too scarred in after ABABR. Thus, intraperitoneal underlay mesh with primary fascial closure or primary closure with onlay mesh placement should then be considered.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Rhemtulla IA, Mauch JT, McCarty EB, et al. Incisional Hernia Incidence, Repair Techniques, and Outcomes Based on 1600 Consecutive Patients Receiving Abdominally Based Autologous Breast Reconstruction. Ann Plast Surg. 2021. PMID: 33470628. doi:10.1097/SAP.0000000000002671

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。